A single early postnatal estradiol injection affects morphology and gene expression of the ovary and parametrial adipose tissue in adult female rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 1-3, 2010, Pages 82-90

  Alexanderson, Camilla ^a   Stener Victorin, Elisabet ^a   Kullberg, Joel ^b   Nilsson, Staffan ^c   Levin, Max ^d   Cajander, Stefan ^b   Lönn, Lars ^e   Lönn, Malin ^d   Holmäng, Agneta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e University of Copenhagen   (Denmark)

Author keywords

Estradiol; Ovary; Parametrial adipose tissue; Programming

Indexed keywords

ADIPONECTIN; COMPLEMENT COMPONENT C3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; LEPTIN; LIPOPROTEIN LIPASE; MESSENGER RNA; CHOLESTEROL ESTERASE; RNA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOVULATION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; METABOLISM; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; RAT; REPRODUCTION; TISSUE METABOLISM; VAGINA DISEASE; ADIPOCYTE; ANIMAL; CHEMISTRY; CYTOCHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; PHOTON ABSORPTIOMETRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; WISTAR RAT;

ABSORPTIOMETRY, PHOTON; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANIMALS, NEWBORN; COMPLEMENT C3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GLUCOSE TRANSPORTER TYPE 3; GLUCOSE TRANSPORTER TYPE 4; HISTOCYTOCHEMISTRY; LEPTIN; LIPOPROTEIN LIPASE; MAGNETIC RESONANCE IMAGING; OVARY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEROL ESTERASE;

RATTUS;

EID: 77956468655     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.10.006     Document Type: Article

References (83)

1. Lucas A. Programming by early nutrition in man. Ciba Foundation Symposium 1991, 156:38-50. (discussion 50-35).
2. Davies M., Norman R. Programming and reproductive functioning. Trends in Endocrinology and Metabolism 2002, 13(9):386-392.
3. Barker D., Hales C., Fall C., Osmond C., Phipps K., Clark P. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36(1):62-67.
4. Phillips D. Birth weight and the future development of diabetes. A review of the evidence. Diabetes Care 1998, 21(Suppl. 2):B150-B155.
5. Colborn T., vom Saal F., Soto A. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives 1993, 101(5):378-384.
6. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. International Journal of Andrology 2008, 31(2):201-208.
7. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environmental Health Perspectives 1995, 103(Suppl. 7 (0091-6765 (Print))):83-87.
8. Nilsson C., Niklasson M., Eriksson E., Bjorntorp P., Holmang A. Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. Journal of Clinical Investigations 1998, 101(1):74-78.
9. Alexanderson C., Eriksson E., Stener-Victorin E., Lystig T., Gabrielsson B., Lonn M., Holmang A. Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone. Endocrinology 2007, 148(11):5369-5376.
10. Abbott D., Padmanabhan V., Dumesic D. Contributions of androgen and estrogen to fetal programming of ovarian dysfunction. Reproductive Biology and Endocrinology 2006, 4:17.
11. Alexanderson C., Eriksson E., Stener-Victorin E., Lonn M., Holmang A. Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle. Journal of Endocrinology 2009, 201(1):49-58.
12. Cooke P., Naaz A. Role of estrogens in adipocyte development and function. Experimental Biology and Medicine 2004, 229(11):1127-1135.
13. Spalding K., Arner E., Westermark P., Bernard S., Buchholz B., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453(7196):783-787.
14. Wade G., Gray J., Bartness T. Gonadal influences on adiposity. International Journal of Obesity 1985, 9(Suppl. 1):83-92.
15. Brodie A., Schwarzel W., Shaikh A., Brodie H. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 1977, 100(6):1684-1695.
16. Shaikh A., Shaikh S. Adrenal and ovarian steroid secretion in the rat estrous cycle temporally related to gonadotropins and steroid levels found in peripheral plasma. Endocrinology 1975, 96(1):37-44.
17. Krotkiewski M. The effects of estrogens on regional adipose tissue cellularity in the rat. Acta Physiologica Scandinavica 1976, 96(1):128-133.
18. Krotkiewski M., Bjorntorp P. The effect of progesterone and of insulin administration on regional adipose tissue cellularity in the rat. Acta Physiologica Scandinavica 1976, 96(1):122-127.
19. Steingrimsdottir L., Brasel J., Greenwood M. Hormonal modulation of adipose tissue lipoprotein lipase may alter food intake in rats. American Journal of Physiology-Endocrinology Metabolism 1980, 239(2):E162-E167.
20. Rodriguez-Cuenca S., Monjo M., Proenza A., Roca P. Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. American Journal of Physiology-Endocrinology Metabolism 2005, 288(1):E200-E207.
21. Wade G., Gray J. Cytoplasmic 17 beta-[3H]estradiol binding in rat adipose tissues. Endocrinology 1978, 103(5):1695-1701.
22. Johnson D., Flask C., Ernsberger P., Wong W.C.K., Wilson D. Reproducible MRI measurement of adipose tissue volumes in genetic and dietary rodent obesity models. Journal of Magnetic Resonance Imaging 2008, 28(4):915-927.
23. Hirshfield A. Development of follicles in the mammalian ovary. International Review of Cytology 1991, 124:43-101.
24. Rajah R., Glaser E., Hirshfield A. The changing architecture of the neonatal rat ovary during histogenesis. Developmental Dynamics 1992, 194(3):177-192.
25. Aihara M., Hayashi S. Induction of persistent diestrus followed by persistent estrus is indicative of delayed maturation of tonic gonadotropin-releasing systems in rats. Biology of Reproduction 1989, 40(1):96-101.
26. Sotomayor-Zarate R., Dorfman M., Paredes A., Lara H. Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biological Reproduction 2007, 78:673-680.
27. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine Reviews 1996, 17(2):121-155.
28. McNatty K., Fidler A., Juengel J., Quirke L., Smith P., Heath D., Lundy T., O'Connell A., Tisdall D. Growth and paracrine factors regulating follicular formation and cellular function. Molecular and Cellular Endocrinology 2000, 163(1-2):11-20.
29. Marcondes F., Bianchi F., Tanni A. Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 2002, 62:609-614.
30. Peterson J., Olivecrona T., Bengtsson-Olivecrona G. Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia. Biochimica et Biophysica Acta 1985, 837(3):262-270.
31. Spooner P., Garrison M., Scow R. Regulation of mammary and adipose tissue lipoprotein lipase and blood triacylglycerol in rats during late pregnancy. Effect of prostaglandins. Journal of Clinical Investigations 1977, 60(3):702-708.
32. Hirshfield A., Midgley A. Morphometric analysis of follicular development in the rat. Biology of Reproduction 1978, 19(3):597-605.
33. Andersen C., Jensen J., Orntoft T. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Research 2004, 64(15):5245-5250.
34. Livak K., Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 2001, 25(4):402-408.
35. Arai Y. Persistent-estrous and -diestrous conditions induced by early postnatal administration of estrogen in female rats. Endocrinologia Japonica 1964, 11(3):204-208.
36. Pinilla L., Barreiro M., Gonzalez L., Tena-Sempere M., Aguilar E. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. Journal of Endocrinology 2002, 172(3):441-448.
37. Ghizzoni L., Barreca A., Mastorakos G., Furlini M., Vottero A., Ferrari B., Chrousos G., Bernasconi S. Leptin inhibits steroid biosynthesis by human granulosa-lutein cells. Hormone and Metabolic Research 2001, 33(June (6)):323-328.
38. Barraclough C. Sex differentiation of cyclic gonadotropin secretion. Advances in the Biosciences 1979, 433. Pergamon Press, Oxford. K.M. Kaye, A.M. Kaye (Eds.).
39. Falvo R., Buhl A., Nalbandov A. Testerone concentrations in the peripheral plasma of adrogenized female rats and in the estrous cycle of normal female rats. Endocrinology 1974, 95(1):26-29.
40. Gilling-Smith C., Willis D., Beard R., Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 1994, 79(4):1158-1165.
41. McNatty K., Makris A., Reinhold V., De Grazia C., Osathanondh R., Ryan K. Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids 1979, 34(4):429-443.
42. Lagaly D., Aad P., Grado-Ahuir J., Hulsey L., Spicer L. Role of adiponectin in regulating ovarian theca and granulosa cell function. Molecular and Cellular Endocrinology 2008, 284(1-2):38-45.
43. Knight P., Glister C. Local roles of TGF-[beta] superfamily members in the control of ovarian follicle development. Animal Reproduction Science 2003, 78(3-4):165-183.
44. Knight P., Glister C. TGF-{beta} superfamily members and ovarian follicle development. Reproduction 2006, 132(2):191-206.
45. Bristol S., Woodruff T. Follicle-restricted compartmentalization of transforming growth factor {beta} superfamily ligands in the feline ovary. Biology of Reproduction 2004, 70(3):846-859.
46. Drummond A., Dyson M., Tan Le M., Ethier J.-F., Findlay J. Ovarian follicle populations of the rat express TGF-[beta] signalling pathways. Molecular and Cellular Endocrinology 2003, 202(1-2):53-57.
47. Erickson G., Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reproductive Biology and Endocrinology 2003, 1(1):9.
48. Shimasaki S., Zachow R., Li D., Kim H., Iemura S.-I., Ueno N., Sampath K., Chang R., Erickson G. A functional bone morphogenetic protein system in the ovary. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:7282-7287.
49. Fortune J. The early stages of follicular development: activation of primordial follicles and growth of preantral follicles. Animal Reproduction Science 2003, 78(3-4):135-163.
50. Juengel J., McNatty K. The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development. Human Reproductive Update 2005, 11(2):144-161.
51. Trombly D., Woodruff T., Mayo K. Roles for transforming growth factor beta superfamily proteins in early folliculogenesis. Seminars in Reproductive Medicine 2009, 27:14-23.
52. Dunkel L., Tilly J., Shikone T., Nishimori K., Hsueh A. Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by the opposing actions of transforming growth factors beta and alpha. Biology of Reproduction 1994, 50(4):940-948.
53. Dorrington J., Bendell J., Khan S. Interactions between FSH, estradiol-17 beta and transforming growth factor-beta regulate growth and differentiation in the rat gonad. Journal of Steroid Biochemistry and Molecular Biology 1993, 44(4-6):441-447.
54. Drummond A., Dyson M., Thean E., Groome N., Robertson D., Findlay J. Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries. Journal of Endocrinology 2000, 166(2):339-354.
55. Hernandez E., Hurwitz A., Payne D., Dharmarajan A., Purchio A., Adashi E. Transforming growth factor-beta 1 inhibits ovarian androgen production: gene expression, cellular localization, mechanisms(s), and site(s) of action. Endocrinology 1990, 127(6):2804-2811.
56. Hutchinson L., Findlay J., de Vos F., Robertson D. Effects of bovine inhibin, transforming growth factor-[beta] and bovine activin-A on granulosa cell differentiation. Biochemical and Biophysical Research Communications 1987, 146(3):1405-1412.
57. Kim I., Schomberg D. The production of transforming growth factor-beta activity by rat granulosa cell cultures. Endocrinology 1989, 124(0013-7227 (Print)):1345-1351.
58. Zhang J., Findlay R., Carson A., Herington H., Burger H. Transforming growth factor beta enhances basal and FSH-stimulated inhibin production by rat granulosa cells in vitro. Molecular and Cellular Endocrinology 1988, 58:161-166.
59. Demeter-Arlotto M., Rainey W., Simpson E. Maintenance and regulation of 17 alpha-hydroxylase expression by bovine thecal cells in primary culture. Endocrinology 1993, 132(3):1353-1358.
60. Fournet N., Weitsman S., Zachow R., Magoffin D. Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism. Endocrinology 1996, 137(1):166-174.
61. Kipp J., Kilen S., Bristol-Gould S., Woodruff T., Mayo K. Neonatal exposure to estrogens suppresses activin expression and signaling in the mouse ovary. Endocrinology 2007, 148(5):1968-1976.
62. Couse J., Korach K. Contrasting phenotypes in reproductive tissues of female estrogen receptor null mice. Annals of the New York Academy of Sciences 2001, 948(1):1-8.
63. Tomic D., Frech M., Babus J., Symonds D., Furth P., Koos R., Flaws J. Effects of ER[alpha] overexpression on female reproduction in mice. Reproductive Toxicology 2007, 23(3):317-325.
64. Ikeda Y., Nagai A., Ikeda M., Hayashi S. Neonatal estrogen exposure inhibits steroidogenesis in the developing rat ovary. Developmental Dynamics 2001, 221(4):443-453.
65. Chabrolle C., Tosca L., Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 2007, 133(4):719-731.
66. Ledoux S., Campos D., Lopes F., Dobias-Goff M., Palin M., Murphy B. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 2006, 147(11):5178-5186.
67. Trujillo M., Scherer P. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine 2005, 257(2):167-175.
68. Kol S., Ben-Shlomo I., Ruutiainen K., Ando M., Davies-Hill T., Rohan R., Simpson I., Adashi E. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. Journal of Clinical Investigations 1997, 99(9):2274-2283.
69. Roberts R., Stark J., Iatropoulou A., Becker D., Franks S., Hardy K. Energy substrate metabolism of mouse cumulus-oocyte complexes: response to follicle-stimulating hormone is mediated by the phosphatidylinositol 3-kinase pathway and is associated with oocyte maturation. Biology of Reproduction 2004, 71(1):199-209.
70. Ceddia R., Somwar R., Maida A., Fang X., Bikopoulos G., Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 2005, 48(1):132-139.
71. Barnum S.R., Volanakis J.E. Structure and function of C3. Year in Immunology 1989, 6:208-228.
72. Cianflone K., Xia Z., Chen L. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta (BBA)-Biomembranes 2003, 1609(2):127-143.
73. van Oostrom A., Alipour A., Plokker T., Sniderman A., Cabezas M. The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 2007, 190(1):167-173.
74. Verseyden C., Meijssen S., van Dijk H., Jansen H., Cabezas M. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. Journal of Lipid Research 2003, 44(11):2100-2108.
75. Halkes C., van Dijk H., de Jaegere P., Plokker H., van der Helm Y., Erkelens D., Castro Cabezas M. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin, arteriosclerosis. Thrombosis and Vascular Biology 2001, 21(9):1526-1530.
76. Cianflone K., Maslowska M., Sniderman A. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Seminars in Cell & Developmental Biology 1999, 10(1):31-41.
77. Germinario R., Sniderman A., Manuel S., Lefebvre S., Baldo A., Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 1993, 42(5):574-580.
78. Tao Y., Cianflone K., Sniderman A., Colby-Germinario S., Germinario R. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1997, 1344(3):221-229.
79. Hamosh M., Hamosh P. The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. Journal of Clinical Investigations 1975, 55(5):1132-1135.
80. Enerback S., Gimble J. Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1993, 1169(2):107-125.
81. Ottosson M., Vikman-Adolfsson K., Enerback S., Elander A., Bjorntorp P., Eden S. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. Journal of Clinical Endocrinology and Metabolism 1995, 80(3):936-941.
82. Yasruel Z., Cianflone K., Sniderman A., Rosenbloom M., Walsh M., Rodriguez M. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991, 26(7):495-499.
83. Murray I., Havel P., Sniderman A., Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000, 141(3):1041-1049.